Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

Regional associations between amyloid and glucose metabolism during the progression of Alzheimer’s disease in Down syndrome

Matthew Zammit, Charles Laymon, Dana Tudorascu, Alexandra DiFilippo, Tyler Tullis, Andrew McVea, Ann Cohen, Davneet Minhas, Shahid Zaman, Beau Ances, Sigan Hartley, Sterling Johnson, Charles Stone, Chester Mathis, William Klunk, Benjamin Handen and Bradley Christian
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 21;
Matthew Zammit
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Laymon
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana Tudorascu
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra DiFilippo
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tyler Tullis
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew McVea
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Cohen
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Davneet Minhas
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahid Zaman
3University of Cambridge Cambridge United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beau Ances
4Washington University in St. Louis St. Louis MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sigan Hartley
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sterling Johnson
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Stone
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chester Mathis
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Klunk
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Handen
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley Christian
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

21

Background: Adults with Down syndrome (DS) carry a triplicate copy of chromosome 21 resulting in the overproduction of amyloid precursor protein, with earliest deposition of Aβ plaques predominantly in the striatum. The relationship between amyloid overproduction and neurodegeneration in DS is not yet understood but will be valuable to compare against the observed patterns in late-onset Alzheimer’s disease (AD).

Objectives: The goal of this study is to relate PiB measured Aβ deposition to regional glucose metabolism during the progression of AD in DS, with a focus on the striatum to identify how the prominence and duration of Aβ in this region influences neurodegeneration.

Methods: A subgroup of 81 adults with DS (age = 38.9 ± 8.3 years) from the ongoing Alzheimer’s Biomarker Consortium-Down Syndrome study (ABC-DS) underwent [F-18]FDG PET in addition to [C-11]PiB. 50-70 minute PiB SUVr and 40-60 minute FDG SUVr images were created using cerebellar gray matter as a reference region. The images were spatially normalized to MNI152 space using DS-specific PET templates for PiB and FDG. Voxel-based regressions were performed between the PiB and FDG images using the Biological Parametric Mapping toolbox in SPM8. The resulting T-statistic maps were evaluated at an uncorrected height threshold of P = 0.001. Additionally, an ROI-based analysis was performed between PiB and FDG SUVr in the caudate and putamen using Pearson’s correlations.

Results: The voxel-based analysis revealed significant negative associations between PiB and FDG in the cingulate, temporal cortex, parietal cortex and precuneus (Figure 1). The regional analysis showed no significant association between PiB and FDG in the caudate (Pearson’s R[95% CI’s] = -0.07[-0.28, 0.15], P = 0.53) or putamen (Pearson’s R = 0.00[-0.21, 0.21], P = 0.99) (Figure 2). Discussion: These results reveal patterns of regional hypometabolism during AD progression in DS. Significant negative associations between PiB and FDG in DS (notably in the temporal cortex, parietal cortex and precuneus) are similar to that observed in late-onset AD (including the lack of association in frontal cortex). Although the caudate and putamen are the earliest regions showing PiB-binding (and so of deposition of Aβ), no significant reductions in metabolism are evident, suggesting the localization of Aβ in these regions may not lead to neurodegeneration as measured with FDG.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Regional associations between amyloid and glucose metabolism during the progression of Alzheimer’s disease in Down syndrome
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Regional associations between amyloid and glucose metabolism during the progression of Alzheimer’s disease in Down syndrome
Matthew Zammit, Charles Laymon, Dana Tudorascu, Alexandra DiFilippo, Tyler Tullis, Andrew McVea, Ann Cohen, Davneet Minhas, Shahid Zaman, Beau Ances, Sigan Hartley, Sterling Johnson, Charles Stone, Chester Mathis, William Klunk, Benjamin Handen, Bradley Christian
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 21;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Regional associations between amyloid and glucose metabolism during the progression of Alzheimer’s disease in Down syndrome
Matthew Zammit, Charles Laymon, Dana Tudorascu, Alexandra DiFilippo, Tyler Tullis, Andrew McVea, Ann Cohen, Davneet Minhas, Shahid Zaman, Beau Ances, Sigan Hartley, Sterling Johnson, Charles Stone, Chester Mathis, William Klunk, Benjamin Handen, Bradley Christian
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 21;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET CT Quantification to direct Alzheimer’s patients to anti-amyloid therapy
  • Multicenter trial study for usefulness of physical parameters toward the standardization of brain SPECT image: relation to visual analysis
  • Assessment of Brain Perfusion 123I-IMP SPECT imaging Using Low Energy High Resolution Collimator image reconstructed by Flash 3D
Show more Neurosciences

Brain Imaging Council YIA Symposium

  • Visualizing innate immune activation in a mouse model of Parkinson’s disease using a highly specific TREM1-PET tracer.
  • Resistance to Tau and Amyloid Pathology Facilitates Super-Aging
  • Stimulation-induced cerebellar syndromes in VIM/DRT-DBS: An FDG PET activation study
Show more Brain Imaging Council YIA Symposium

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire